Morgan Stanley’s Apigee Corporation Common Stock APIC Stock Holding History

Morgan Stanley’s Portfolio APIC Stock Details APIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-444,740	Closed	-$7.74M	–	6672
2016 Q3	$7.74M	Buy	444,740 +380,441	+592%	+$5.56M	﹤0.01%	2242
2016 Q2	$786K	Sell	64,299 -20,001	-24%	-$213K	﹤0.01%	4151
2016 Q1	$701K	Sell	84,300 -11,718	-12%	-$87.3K	﹤0.01%	4210
2015 Q4	$772K	Buy	96,018 +36,516	+61%	+$319K	﹤0.01%	4236
2015 Q3	$628K	Buy	59,502 +24,155	+68%	+$209K	﹤0.01%	4465
2015 Q2	$351K	Buy	+35,347	New	+$485K	﹤0.01%	4937

Morgan Stanley's APIC Position: Q4 2016 in Review

Morgan Stanley sold out of Apigee Corporation Common Stock (APIC) in Q4 2016, closing a stake of 444,740 shares — an estimated $7.74M sold.

Morgan Stanley first reported a position in APIC in Q2 2015 and held it in 6 quarters. The position peaked at $7.74M in Q3 2016. 0 funds tracked by Wall St. Rank hold APIC as of Q4 2016.

Morgan Stanley reported no remaining Apigee Corporation Common Stock position as of Q4 2016 after selling out during the quarter.
Morgan Stanley sold 444,740 Apigee Corporation Common Stock shares in Q4 2016, an estimated $7.74M.
Morgan Stanley first reported a position in Apigee Corporation Common Stock in Q2 2015 and held it in 6 quarters.
Morgan Stanley's Apigee Corporation Common Stock position peaked at $7.74M in Q3 2016.
0 funds tracked by Wall St. Rank held Apigee Corporation Common Stock as of Q4 2016.

Based on Morgan Stanley's 13F filing for Q4 2016, filed 13 Feb 2017.